Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
13F holders, Q3 2024
Institutional positions in Adma Biologics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 306
- +54 vs. Q2 2024
- Shares held
- 208.7M
- +46.2M (+28.5%) vs. Q2 2024
- Total value
- $4.16B
- +$2.34B (+128.9%) vs. Q2 2024
- New holders
- 93
- 102 more added
- Sold out
- 39
- 95 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $1.70B |
| Q1 2026 | 358 | $1.91B |
| Q4 2025 | 357 | $4.02B |
| Q3 2025 | 366 | $3.28B |
| Q2 2025 | 369 | $3.84B |
| Q1 2025 | 347 | $4.07B |
| Q4 2024 | 321 | $3.50B |
| Q3 2024 | 306 | $4.16B |
| Q2 2024 | 253 | $2.03B |
| Q1 2024 | 214 | $1.16B |
| Q4 2023 | 184 | $764.6M |
| Q3 2023 | 188 | $612.7M |
| Q2 2023 | 179 | $610.6M |
| Q1 2023 | 163 | $547.2M |
| Q4 2022 | 160 | $592.2M |
| Q3 2022 | 130 | $315.4M |
| Q2 2022 | 113 | $236.0M |
| Q1 2022 | 105 | $189.9M |
| Q4 2021 | 88 | $137.1M |
| Q3 2021 | 72 | $47.3M |
| Q2 2021 | 90 | $68.6M |
| Q1 2021 | 104 | $85.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 8,599,618 | $171.9M | 0.01% | +4,001,131+87.0% | Added |
| Invesco Ltd. | 12,619,769 | $252.3M | 0.05% | −550,967−4.2% | Reduced |
| State Street Corp | 13,004,993 | $260.0M | 0.01% | +4,945,063+61.4% | Added |
| Vanguard Group Inc | 18,118,494 | $362.2M | 0.01% | +3,601,842+24.8% | Added |
| BlackRock, Inc. | 38,269,434 | $765.0M | 0.02% | +38,269,434 | New |
| Coppell Advisory Solutions LLC | 838 | – | – | −950−53.1% | Reduced |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −493,311−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −463,685−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −260,200−100.0% | Sold out |
| Brant Point Investment Management LLC | 0 | $0 | 0.00% | −124,626−100.0% | Sold out |
| Semanteon Capital Management, LP | 0 | $0 | 0.00% | −110,509−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −88,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −77,105−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −73,968−100.0% | Sold out |
| EWG Elevate Inc. | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −56,864−100.0% | Sold out |
| Verdad Advisers, LP | 0 | $0 | 0.00% | −49,018−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −40,277−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −34,055−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −30,351−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −26,800−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −20,532−100.0% | Sold out |
| Viewpoint Capital Management LLC | 0 | $0 | 0.00% | −20,416−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −15,892−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −15,615−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,896−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,544−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −12,374−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −12,247−100.0% | Sold out |
| TrinityPoint Wealth, LLC | 0 | $0 | 0.00% | −10,841−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −10,474−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −10,204−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −2,630−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −2,156−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,156−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −692−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −213−100.0% | Sold out |
| Abich Financial Wealth Management LLC | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |